Shaowei Wang

Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

SUMOylation and ubiquitination reciprocally regulate SMCHD1 antiviral activity against herpes simplex virus 1.

SUMOylation and ubiquitination reciprocally regulate SMCHD1 antiviral activity against herpes simplex virus 1.

Journal: PLoS pathogens
Published: January 15, 2026

Human-specific activation of the DUX4-SLC34A2 axis by herpesviruses suppresses antiviral innate immunity.

Human-specific activation of the DUX4-SLC34A2 axis by herpesviruses suppresses antiviral innate immunity.

Journal: mBio
Published: November 10, 2025

Targeting the LHX1-LDB1 Complex Restores STING-dependent Senescence Surveillance and Inhibits Head and Neck Cancer Progression.

Targeting the LHX1-LDB1 Complex Restores STING-dependent Senescence Surveillance and Inhibits Head and Neck Cancer Progression.

Journal: International journal of biological sciences
Published: August 15, 2025

Disrupting the OTUD4-USP7 deubiquitinase complex to suppress herpesvirus replication: a novel antiviral strategy.

Disrupting the OTUD4-USP7 deubiquitinase complex to suppress herpesvirus replication: a novel antiviral strategy.

Journal: PLoS pathogens
Published: October 10, 2024

Palmitoylation of KSHV pORF55 is required for Golgi localization and efficient progeny virion production.

Palmitoylation of KSHV pORF55 is required for Golgi localization and efficient progeny virion production.

Journal: PLoS pathogens
Published: November 15, 2023

Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases.

Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases.

Journal: PLoS pathogens
Published: September 26, 2023

Genome-Wide CRISPR-Cas9 Screen Identifies SMCHD1 as a Restriction Factor for Herpesviruses.

Genome-Wide CRISPR-Cas9 Screen Identifies SMCHD1 as a Restriction Factor for Herpesviruses.

Journal: mBio
Published: April 03, 2023

Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity.

Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity.

Journal: Molecular therapy oncolytics
Published: January 13, 2023

STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2.

STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2.

Journal: Nature cell biology
Published: May 05, 2022
Showing 1-9 of 9

Last Updated: 09/26/2026